Sign in

These emergency-use medicines may get cheaper as govt fixes ceiling price

Four emergency-use medicines -- Ipratropium, Sodium Nitroprusside, Diltiazem and Povidone Iodine, reportedly have fixed ceiling prices now.

Published on: Aug 8, 2025, 13:18:57 IST
Share
Share via
  • facebook
  • twitter
  • linkedin
  • whatsapp
Copy link
  • copy link

The ceiling prices of four emergency-use medicines have been fixed by the government, which means manufactures currently selling them for higher will have to lower the amount they charge.

An employee sorts medicines in a medicine wholesale shop in Lucknow, India, Thursday, Aug. 7, 2025 (AP Photo/Rajesh Kumar Singh) (AP)
An employee sorts medicines in a medicine wholesale shop in Lucknow, India, Thursday, Aug. 7, 2025 (AP Photo/Rajesh Kumar Singh) (AP)

According to a Times of India report, four emergency-use medicines -- Ipratropium, Sodium Nitroprusside, Diltiazem and Povidone Iodine, have fixed ceiling prices now, and the retail prices of 37 other drug formulations have also been fixed.

The National Pharmaceutical Pricing Authority (NPPA) has reportedly said that manufacturers selling these branded or generic medicines will have to reduce the pricing if the current rate exceeds the ceiling price (plus GST).

Ipratropium, usually used to treat pulmonary diseases and for asthma, shortness of breath or runny nose, etc has been fixed at 2.96 per ml. Sodium nitroprusside, used for heart-related ailments and to lower dangerously shot up blood pressure, has been fixed at 28.99 per ml.

Diltiazem, another medicine used to control high blood pressure, and chest pain, has been capped at 26.72 per capsule. The last emergency-use medicine is Povidone Iodine, used to treat skin disinfection before and after surgeries or minor wounds, and has been capped at 6.26 per gram, the TOI report further added.

Besides, the retail prices of 37 drugs from companies has been fixed, including antibiotics and painkillers.

"Manufacturers selling branded or generic or both versions of the medicines at a price higher than ceiling price (plus GST) shall revise the prices downward not exceeding the ceiling price...," the publication quoted the NPPA as saying.

Meanwhile, those already selling the medicines at a price lower than the cap can continue to do so.

  • HT News Desk
    ABOUT THE AUTHOR
    HT News Desk

    Follow the latest breaking news, major developments and agenda-setting stories from India and around the world with the newsdesk at Hindustan Times. Operating round the clock, the desk brings together experienced editors, reporters and correspondents to deliver fast, accurate and contextual reporting across subjects that influence public policy, governance, business, society and international affairs. The HT News Desk covers politics, elections, government policies, the economy, business and markets, science and technology, the environment, law and order, infrastructure, education, climate issues and geopolitics, while closely tracking developments across states, institutions and global capitals. The team also leads coverage of major breaking news events, policy announcements, court proceedings, natural disasters, public emergencies and significant international developments. Reports published by the newsdesk are based on information gathered from reporters on the ground, official statements, government agencies, court records, regulatory filings, recognised institutions and other authoritative sources. Stories undergo editorial scrutiny and verification processes to ensure accuracy, fairness and relevance, and are updated as events evolve and additional information becomes available. Whether covering a key political decision in New Delhi, an economic policy shift affecting millions, a landmark court ruling or a major global event, the HT News Desk aims to provide readers with reliable, fact-based journalism that delivers not only the latest developments but also the context and analysis needed to understand their wider implications.Read More